Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Non Operating Income (2016 - 2025)

Traws Pharma (TRAW) has disclosed Non Operating Income for 14 consecutive years, with $14000.0 as the latest value for Q4 2025.

  • For Q4 2025, Non Operating Income rose 106.8% year-over-year to $14000.0; the TTM value through Dec 2025 reached $478000.0, up 65.4%, while the annual FY2025 figure was $478000.0, 65.4% up from the prior year.
  • Non Operating Income hit $14000.0 in Q4 2025 for Traws Pharma, down from $96000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $362000.0 in Q1 2023 and bottomed at -$206000.0 in Q4 2024.
  • Average Non Operating Income over 5 years is $139600.0, with a median of $138000.0 recorded in 2022.
  • Year-over-year, Non Operating Income skyrocketed 31500.0% in 2022 and then crashed 174.1% in 2024.
  • Traws Pharma's Non Operating Income stood at -$1000.0 in 2021, then surged by 31500.0% to $314000.0 in 2022, then fell by 11.46% to $278000.0 in 2023, then crashed by 174.1% to -$206000.0 in 2024, then skyrocketed by 106.8% to $14000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $14000.0, $96000.0, and $188000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.